Literature DB >> 31644312

Effects of hyperoxia on alveolar and pulmonary vascular development in germ-free mice.

Kalsang Dolma1,2, Amelia E Freeman1, Gabriel Rezonzew1, Gregory A Payne3, Xin Xu3, Tamas Jilling1, J Edwin Blalock3, Amit Gaggar3, Namasivayam Ambalavanan1, Charitharth Vivek Lal1,2.   

Abstract

Airway microbial dysbiosis is associated with subsequent bronchopulmonary dysplasia (BPD) development in very preterm infants. However, the relationship of airway microbiome in normal pulmonary development has not been defined. To better understand the role of the airway microbiome, we compared normal and abnormal alveolar and pulmonary vascular development in mice with or without a microbiome. We hypothesized that the lungs of germ-free (GF) mice would have an exaggerated phenotypic response to hyperoxia compared with non-germ-free (NGF) mice. With the use of a novel gnotobiotic hyperoxia chamber, GF and NGF mice were exposed to either normoxia or hyperoxia. Alveolar morphometry, pulmonary mechanics, echocardiograms, inflammatory markers, and measures of pulmonary hypertension were studied. GF and NGF mice in normoxia showed no difference, whereas GF mice in hyperoxia showed protected lung structure and mechanics and decreased markers of inflammation compared with NGF mice. We speculate that an increase in abundance of pathogenic bacteria in NGF mice may play a role in BPD pathogenesis by regulating the proinflammatory signaling and neutrophilic inflammation in lungs. Manipulation of the airway microbiome may be a potential therapeutic intervention in BPD and other lung diseases.

Entities:  

Keywords:  bronchopulmonary dysplasia; germ free; gnotobiotic; hyperoxia; lung microbiome

Mesh:

Year:  2019        PMID: 31644312      PMCID: PMC7052667          DOI: 10.1152/ajplung.00316.2019

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  35 in total

1.  Iloprost attenuates hyperoxia-mediated impairment of lung development in newborn mice.

Authors:  Nelida Olave; Charitharth Vivek Lal; Brian Halloran; Vineet Bhandari; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-06-28       Impact factor: 5.464

2.  Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study.

Authors:  Marianne S Muhlebach; Joseph E Hatch; Gisli G Einarsson; Stef J McGrath; Deirdre F Gilipin; Gillian Lavelle; Bojana Mirkovic; Michelle A Murray; Paul McNally; Nathan Gotman; Sonia Davis Thomas; Matthew C Wolfgang; Peter H Gilligan; Noel G McElvaney; J Stuart Elborn; Richard C Boucher; Michael M Tunney
Journal:  Eur Respir J       Date:  2018-07-11       Impact factor: 16.671

3.  Isolation of keratinophilic fungi from soil in Pavia, Italy.

Authors:  G Caretta; E Piontelli
Journal:  Sabouraudia       Date:  1975-03

4.  Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone.

Authors:  Teodora Nicola; Namasivayam Ambalavanan; Wei Zhang; Masheika L James; Virender Rehan; Brian Halloran; Nelida Olave; Arlene Bulger; Suzanne Oparil; Yiu-Fai Chen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-29       Impact factor: 5.464

5.  VARA attenuates hyperoxia-induced impaired alveolar development and lung function in newborn mice.

Authors:  Masheika L James; A Catharine Ross; Teodora Nicola; Chad Steele; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-12       Impact factor: 5.464

Review 6.  Bronchopulmonary dysplasia: a review.

Authors:  Zarqa Ali; Peter Schmidt; James Dodd; Dorthe Lisbeth Jeppesen
Journal:  Arch Gynecol Obstet       Date:  2013-02-19       Impact factor: 2.344

7.  Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia.

Authors:  J J Coalson; V Winter; R A deLemos
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

8.  ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat.

Authors:  V S DiCarlo; S J Chen; Q C Meng; J Durand; M Yano; Y F Chen; S Oparil
Journal:  Am J Physiol       Date:  1995-11

9.  Molecular microbiological characterization of preterm neonates at risk of bronchopulmonary dysplasia.

Authors:  Matthew S Payne; Kevin C W Goss; Gary J Connett; Tanoj Kollamparambil; Julian P Legg; Richard Thwaites; Mark Ashton; Victoria Puddy; Janet L Peacock; Kenneth D Bruce
Journal:  Pediatr Res       Date:  2010-04       Impact factor: 3.756

10.  Airway Microbial Community Turnover Differs by BPD Severity in Ventilated Preterm Infants.

Authors:  Brandie D Wagner; Marci K Sontag; J Kirk Harris; Joshua I Miller; Lindsey Morrow; Charles E Robertson; Mark Stephens; Brenda B Poindexter; Steven H Abman; Peter M Mourani
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

View more
  10 in total

Review 1.  Malnutrition, poor post-natal growth, intestinal dysbiosis and the developing lung.

Authors:  Mark A Underwood; Satyan Lakshminrusimha; Robin H Steinhorn; Stephen Wedgwood
Journal:  J Perinatol       Date:  2020-10-14       Impact factor: 2.521

2.  Mice without a microbiome are partially protected from lung injury by hyperoxia.

Authors:  Kent A Willis; Joseph F Pierre; Stephania A Cormier; Ajay J Talati
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-30       Impact factor: 5.464

3.  Interactive and independent effects of early lipopolysaccharide and hyperoxia exposure on developing murine lungs.

Authors:  Amrit Kumar Shrestha; Renuka T Menon; Ahmed El-Saie; Roberto Barrios; Corey Reynolds; Binoy Shivanna
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-09-09       Impact factor: 5.464

Review 4.  Novel Strategies to Reduce Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia.

Authors:  Ahmed El-Saie; Binoy Shivanna
Journal:  Front Pediatr       Date:  2020-05-08       Impact factor: 3.418

5.  MicroRNA 219-5p inhibits alveolarization by reducing platelet derived growth factor receptor-alpha.

Authors:  Amelia Freeman; Luhua Qiao; Nelida Olave; Gabriel Rezonzew; Samuel Gentle; Brian Halloran; Gloria S Pryhuber; Amit Gaggar; Trent E Tipple; Namasivayam Ambalavanan; Charitharth Vivek Lal
Journal:  Respir Res       Date:  2021-02-17

Review 6.  When inflammation meets lung development-an update on the pathogenesis of bronchopulmonary dysplasia.

Authors:  Lena Holzfurtner; Tayyab Shahzad; Ying Dong; Lisa Rekers; Ariane Selting; Birte Staude; Tina Lauer; Annesuse Schmidt; Stefano Rivetti; Klaus-Peter Zimmer; Judith Behnke; Saverio Bellusci; Harald Ehrhardt
Journal:  Mol Cell Pediatr       Date:  2022-04-20

7.  Change of intestinal microbiota in mice model of bronchopulmonary dysplasia.

Authors:  Tianqun Fan; Ling Lu; Rong Jin; Aihua Sui; Renzheng Guan; Fengjing Cui; Zhenghai Qu; Dongyun Liu
Journal:  PeerJ       Date:  2022-04-20       Impact factor: 3.061

Review 8.  Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies.

Authors:  Kiersten Giusto; Heather Wanczyk; Todd Jensen; Christine Finck
Journal:  Dis Model Mech       Date:  2021-02-23       Impact factor: 5.758

9.  Toll-like receptors, environmental caging, and lung dysbiosis.

Authors:  Jay H Lipinski; Nicole R Falkowski; Gary B Huffnagle; John R Erb-Downward; Robert P Dickson; Beth B Moore; David N O'Dwyer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-06-23       Impact factor: 6.011

Review 10.  Halogen exposure injury in the developing lung.

Authors:  Dylan R Addis; Adam Molyvdas; Namasivayam Ambalavanan; Sadis Matalon; Tamas Jilling
Journal:  Ann N Y Acad Sci       Date:  2020-08-01       Impact factor: 6.499

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.